Page last updated: 2024-11-12

bim 23056

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16133799
CHEMBL ID410596
SCHEMBL ID12912367
MeSH IDM0242312

Synonyms (15)

Synonym
bim23056
CHEMBL410596
bdbm82256
d-phe-phe-tyr-d-trp-lys-val-phe-d-nal-nh2
bim 23056
dc-25-20
cas_150155-61-6
SCHEMBL12912367
150155-61-6
AKOS024456811
d-alaninamide,d-phenylalanyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-phenylalanyl-3-(2-naphthalenyl)-
ffywkvfa
d-alaninamide, d-phenylalanyl-l-phenylalanyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-phenylalanyl-3-(2-naphthalenyl)-
(2s)-6-amino-n-[(2s)-1-[[(2s)-1-[[(2r)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-2-[[(2r)-2-[[(2s)-2-[[(2s)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyp
PD079144
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID195175In vitro GH release inhibiting potency on anterior pitutaries from adult male rats, relative to somatostatin1995Journal of medicinal chemistry, May-26, Volume: 38, Issue:11
Three-dimensional quantitative structure-activity relationships of somatostatin analogues. 1. Comparative molecular field analysis of growth hormone release-inhibiting potencies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (70.00)18.2507
2000's3 (15.00)29.6817
2010's1 (5.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.70 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]